发明名称 COMPOSITION COMPRISING HYALURONIC ACID AND MEPIVACAINE
摘要 Compositions and methods for the surface appearance of the skin a subject are provided. An injectable composition comprising at least hyaluronic acid or a salt thereof; and an effective amount of at least mepivacaine or a salt thereof are provided. The hyaluronic acid optionally has an average molecular weight ranging from 50,000 to 10,000,000 Daltons, and may be crosslinked hyaluronic acids, non-crosslinked hyaluronic acids, or a combination, in some embodiments. The compositions and methods of the present invention are useful for treating and preventing the cutaneous signs of chronological aging and/or induced by external factors such as stress, air pollution, tobacco or prolonged exposure to ultraviolet (UV) exposure, impaired surface appearance of the skin, impaired viscoelastic or biomechanical properties of the skin, and/or the long-lasting filling of volume defects of the skin.
申请公布号 US2016325021(A1) 申请公布日期 2016.11.10
申请号 US201615214983 申请日期 2016.07.20
申请人 Teoxane 发明人 Bourdon Francois;Meunier Stephane
分类号 A61L27/54;A61L27/12;A61K9/00;A61L27/20 主分类号 A61L27/54
代理机构 代理人
主权项 1. A method comprising: treating (i) skin surface appearance, (ii) cutaneous signs of chronological aging and/or signs induced by external factors such as stress, air pollution, tobacco or prolonged exposure to ultraviolet (UV) exposure,(iii) impaired surface appearance of the skin,(iv) impaired viscoelastic or biomechanical properties of the skin,(v) skin volume defects, and/or(vi) deficiencies and defects in gingival architecture and bony tissue by injecting a single sterile, injectable composition into a patient in need thereof, wherein: the single sterile, injectable composition comprises: (a) an effective amount of hyaluronic acid or a salt thereof; and(b) mepivacaine or a salt thereof as an anesthetic agent at a concentration ranging from 0.05 to 3 wt % of an overall weight of the single, sterile injectable composition.
地址 Geneve CH